Favorable response of metastatic merkel cell carcinoma to targeted 177Lu-DOTATATE therapy: Will PRRT evolve to become an important approach in receptor-positive cases?

No Thumbnail Available

Click here to download

0927.htm (4.54 KB)

Date

2016

Authors

Journal Title

Journal ISSN

Volume Title

Publisher

Abstract

Description

Keywords

Merkel cell carcinoma, 177Lu-DOTATATE, peptide receptor radionuclide therapy, PRRT

Source

Journal of Nuclear Medicine Technology, 2016. Vol. 44 (2): pp. 85-87

URI

http://hdl.handle.net/123456789/14242

Collections

2016